ArticleFrontiers in oncology2025

Integration of single-cell and bulk RNA sequencing to identify unique tumor stem cells and construct novel prognostic markers for assessing ESCA prognosis and drug sensitivity.

Jia Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.